Richard B Lipton MD Prof of Neurology
Headache, Dementia & Geriatrics
Professor, The Saul R. Korey Department of Neurology; Professor, Department of Psychiatry and Behavioral Sciences; Professor, Department of Epidemiology & Population Health; Edwin S. Lowe Chair in Neurology; Vice Chair, The Saul R. Korey Department of Neurology; Director, Montefiore Headache Center, Albert Einstein College of Medicine
Join to View Full Profile
Russo Building1300 Morris Park Ave. Ste. 3Bronx, NY 10461
Phone+1 718-430-3886
Dr. Lipton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board certified academic neurologist. My clinical practice is focused on headache medicine. My research focuses on headache medicine, cognitive aging and dementia. After attending the University of Chicago Pritzker School of Medicine, I completed a neurology residency at Einstein, fellowships in clinical neurophysiology (at Einstein) and neuroepidemiology (at Columbia) and have been Einstein faculty ever since. I am currently the Edwin S. Lowe Professor of Neurology, Professor of Epidemiology and Population Health and Professor of Psychiatry and Behavioral Sciences at Einstein. I conduct longitudinal epidemiological studies and clinical trials funded by the NIH, the FDA and industry.
Education & Training
Montefiore Medical Center/Albert Einstein College of MedicineResidency, Neurology, 1981 - 1986
Northwestern UniversityMD, Medical internship, 1980 - 1981
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1980
U of IllinoisBS, Biology, 1971 - 1975- U of IllinoisBS, Biology, 1971 - 1975
Certifications & Licensure
NY State Medical License 1983 - 2026
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder: The UNITE Randomized Clinical Trial.Richard B Lipton, Verena Ramirez Campos, Zipi Roth-Ben Arie, Maja Galic, Dimos Mitsikostas
JAMA Neurology. 2025-05-05 - Development of Simple Risk Scores for Prediction of Brain β-Amyloid and Tau Status in Older Adults With Mild Cognitive Impairment: A Machine Learning Approach.Kellen K Petersen, Bhargav T Nallapu, Richard B Lipton, Ellen Grober, Christos Davatzikos
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. 2025-05-02 - Multimodal Associations of Modifiable Risk Factors on White Matter Injury: The SOL-INCA-MRI Study (HCHS/SOL).Shraddha Sapkota, Pauline Maillard, Ariana M Stickel, Wassim Tarraf, Kevin A González
Stroke. 2025-05-01
Press Mentions
Migraine Drug Could Be First to Treat Symptoms That Come Before the HeadacheMay 13th, 2025- Theranica Announces Coverage Policy from the Second Largest U.S. Health Insurer for Its Nerivio® REN Wearable Migraine Treatment, Reaching Access for 80 Million AmericansApril 22nd, 2025
- FDA Clears NSAID/Triptan Combo for Migraine in AdultsJanuary 31st, 2025
- Join now to see all
Grant Support
- Validation of the Remote Cognitive Aging and Alzheimer’s Disease REsearch (R-CARE) Toolbox for Diverse PopulationsALBERT EINSTEIN COLLEGE OF MEDICINE2023–2028
- Migraine Clinical Outcome Assessment System (MiCOAS)VECTOR PSYCHOMETRIC GROUP LLC2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
